AlphaStar Capital Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-12,099
Closed -$182K – 253
2025
Q4
$182K Buy
12,099
+258
+2% +$10.2K 0.01% 245
2025
Q3
$171K Buy
11,841
+400
+3% +$14.5K 0.01% 193
2025
Q2
$163K Buy
11,441
+739
+7% +$26.8K 0.01% 354
2025
Q1
$159K Sell
10,702
-12,437
-54% -$493K 0.02% 181
2024
Q4
$333K Buy
+23,139
New +$924K 0.03% 159

Other funds holding BME

AlphaStar Capital Management's BME Position: Q1 2026 in Review

AlphaStar Capital Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 12,099 shares — an estimated $182K sold.

AlphaStar Capital Management first reported a position in BME in Q4 2024 and held it in 5 quarters. The position peaked at $333K in Q4 2024. 77 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • AlphaStar Capital Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • AlphaStar Capital Management sold 12,099 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $182K.
  • AlphaStar Capital Management first reported a position in BlackRock Health Sciences Trust in Q4 2024 and held it in 5 quarters.
  • AlphaStar Capital Management's BlackRock Health Sciences Trust position peaked at $333K in Q4 2024.
  • 77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on AlphaStar Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.